VERU INC (VERU:NASDAQ)
$2.23 -0.05 (-2.193%)
Analysed VERU INC (VERU:NASDAQ) News Sources
Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clinical Trial Results Amid ...
13-05-2026
yahoo.com
Veru Inc. Q2 2026 Earnings Call Summary
15-05-2026
moby.co
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
01-06-2026
stocktwits.com
Veru Teams Up With Novo Nordisk for Obesity Combination Therapy Trial (VERU)
04-06-2026
advfn.com
This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?
04-06-2026
stocktwits.com
Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru Trial
05-06-2026
yahoo.com
Veru And 2 Other Intriguing Penny Stocks To Watch
05-06-2026
yahoo.com
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
07-07-2026
yahoo.com
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
09-07-2026
yahoo.com
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
27-07-2026
yahoo.com
What is the current price of VERU INC (VERU:NASDAQ)?
The current price of VERU INC (VERU:NASDAQ) is $2.23.
VERU INC (VERU:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERU INC (VERU:NASDAQ) since the previous trading day is $-0.05.
VERU INC (VERU:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERU INC (VERU:NASDAQ) since the previous trading day is -2.193%.
What is the most recent average sentiment score for VERU INC (VERU:NASDAQ)?
The most recent average sentiment score for VERU INC (VERU:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for VERU INC (VERU:NASDAQ)?
The most recent sentiment for VERU INC (VERU:NASDAQ) is .
SEC-8K** Filing Available For VERU INC (VERU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.